Med Tech and IVD-related technology assessments from NICE in the second half May 2017

The following technology assessments and clinical guidelines have been already released by National Institute for Health and Care Excellence in second two weeks of May 2017:

• Medtech Innovation Briefings for Permacol (collagen paste that is injected into anal fistulae) and Bindex (portable pulse‑echo ultrasound device used to help make decisions on the investigation and treatment of osteoporosis).
• Interventional Procedure Guidance: Endoscopic full thickness removal of non-lifting colonic polyps
  • This procedure should only be used with special arrangements for clinical governance, consent and audit or research due to inadequate quantity and quality of current evidence on the safety and efficacy

MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety and cost. It does not offer a formal guidance and it therefore does not provide any recommendations.

An Interventional Procedure Guidance is developed for most of the novel interventional procedures entering the English market. The program focuses solely on clinical evidence. Recommendations may vary from ‘for research only’ to ‘for use with standard arrangements for clinical governance, consent and audit’. Recommendations are not binding, although they are followed by providers and commissioners.

Subscribe to our biweekly newsletter not to miss important reimbursement information.